Close
Blog & Resources Camargo Blog August 21st, 2008

PK Modeling, Not Just Any Pretty Face

We recently changed the navigation and look of our website to show that we are a full-service drug development company. 505(b)(2) drug development is so much more than just regulatory submissions! I was asked to explain what the chart is on the pharmacokinetics services ‘page’:

The chart is a result of pharmacokinetic modeling. Note the title: Treatments A &B: Simulated and Actual Data. Modeling is using existing data, usually human pharmacokinetic data (and sometimes in vitro dissolution data) and performing simulations. For example, using data from a single-dose study to predict what a multiple-dose, steady state study would look like. This helps assess what formulation changes might be needed to achieve therapeutic effectiveness while meeting safety parameters.

Many thanks to our intern, Sunny Tse for conducting this modeling.


Get Our Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our solutions or contact us.


Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.


Contact
Headquarters
9825 Kenwood Road,
Suite 203
Cincinnati, OH 45242
Durham Office
2505 Meridian Parkway,
Suite 150
Durham, NC 27713
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights